Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal ...
GRACE - Global Resource for Advancing Cancer Education
Dr. Clark on the Potential of Immunotherapy in Renal Cell Carcinoma
Peter Clark, MD, medical oncologist, Levine Cancer Institute, discusses the potential of immunotherapy in the treatment of patients with renal cell carcinoma ...
OncLiveTV
Immunotherapy of Renal Cell Carcinoma
Hans Hammers, MD, PhD.
Cancer Therapy Advisor
Dr. Albiges on Immunotherapy in Renal Cell Carcinoma
Laurence Albiges, MD, medical oncologist, head, Genitourinary Oncology Unit, Gustave Roussy, discusses how immunotherapy has had an impact on the field ...
OncLiveTV
Creating a Future After Stage 4 Kidney Cancer: Philip’s Immunotherapy Story
Philip Prichard was shocked when he learned he had a 3.8 pound tumor on his right kidney. http://www.cancerresearch.org And when. after surgery and ...
Cancer Research Institute
Dr. Steinberg on Impact of Immunotherapy on Renal Cell Carcinoma
Gary D. Steinberg, MD, Bruce and Beth White Family Professor, professor of Surgery, director, Urologic Oncology, University of Chicago Medicine, discusses the ...
Targeted Oncology
Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma
Bradley McGregor, MD, clinical director of Lank Center for Genitourinary Oncology, senior physician at Dana-Farber Cancer Institute, and instructor of Medicine ...
Targeted Oncology
Dr. Braun on Evolution of Immunotherapy in Advanced Renal Cell Carcinoma
David A. Braun, MD, PhD, physician at Dana-Farber Cancer Institute and instructor of medicine at Harvard Medical School, discusses the evolution of ...
OncLiveTV
A Good Problem to Have | Renal Cell Carcinoma: The New Challenge | MedscapeTV
For full video series on Renal Cell Carcinoma: https://wb.md/2T9THhF Two noted oncologists bring current clinical evidence and their extensive clinical ...
Medscape
Dr JianJun Gao discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapy
At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (The University of Texas MD Anderson Cancer Center, TX) discusses papillary renal ...
EMG-Health
Immunotherapy in Kidney Cancer
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the ...
OncLiveTV
Aggressive Systemic and Multi-Modal Therapy to Treat Metastatic Kidney Cancer | UCLAMDChat
UCLAMDChat UCLA oncologist Sandy Liu, MD, talks about UCLA's multi-disciplinary treatment approach to target advanced kidney cancer. The team ...
UCLA Health
Investigating Immunotherapy Treatment in Renal Cell Carcinoma
Charles G. Drake, MD, PhD, professor of medical oncology at New York Presbyterian/Columbia University Medical Center, discusses his thoughts on whether ...
Targeted Oncology
Life-Changing Renal Cancer Diagnosis: Nancy Whitley’s Story
In 2011, Nancy's daughter took her to the doctor after she had been complaining about flu symptoms all week. After a few tests and scans, they found a tumor ...
uvahealth
Kidney cancer: combining PARP inhibitors and immunotherapy
Tracy Rose, MD, MPH, University of North Carolina, Chapel Hill, NC, discusses PARP inhibitors and new immunotherapy agents for metastatic renal cell ...
VJOncology
Dr. Powles on the Impact of Immunotherapy in Kidney Cancer
OncLiveTV
Upfront Immunotherapy for Metastatic Kidney Cancer
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the ...
OncLiveTV
CrossFitter tackles stage IV kidney cancer
CrossFitter Valerie Smith discusses her experience in a clinical trial combining immunotherapy (interleukin-2) and radiation to combat stage IV kidney cancer.
UTSWMed
Immunotherapy for metastatic RCC - EMPIRE Urology Lecture Series
Dr. A Ari Hakimi discusses Immunotherapy for metastatic renal cell carcinoma 5/28/20.
EMPIRE Urology
Renal Cell Carcinoma
In the United States, there are over 60000 new diagnoses and nearly 14000 deaths from kidney cancer each year. Dr. Won Kim reviews the epidemiology of ...
University of California Television (UCTV)
Renal cell carcinoma trial analysis: current landscape of immunotherapy combinations
Toni Choueiri, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses various immunotherapy combinations showing promising results in early and late ...
VJOncology
Immunotherapy clinical trial gave kidney cancer patient hope
Rick Frantz was diagnosed with stage IV kidney cancer in early 2016. A CT scan at MD Anderson Cancer Center revealed a large tumor on his left kidney and ...
MD Anderson Cancer Center
Stage IV kidney cancer patient sees success with RADVAX trial
72-year-old Larry Carlson was diagnosed with stage IV CCRCC in November of 2014. He came to the UT Southwestern Kidney Cancer Program shortly after.
UTSWMed
Therapeutic algorithm for Renal Cell Carcinoma (RCC)
Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert discussions from physicians and ...
ImedexCME
Engaging the immune system to put stage 4 kidney cancer in remission
An innovative clinical trial using radiation to enhance the efficacy of immunotherapy.
UTSWMed
Mohamad E. Allaf, MD, on immunotherapies and renal cell carcinoma treatment algorithms
Dr. Allaf, MD, Vice Chairman, Department of Urology, Associate Professor of Urology, Johns Hopkins University School of Medicine, gives information on ...
OBRoncology
Anti-VEGF/Immunotherapy Combinations in Kidney Cancer
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for combining VEGF-targeted therapy with ...
OncLiveTV
Kidney Cancer and Immunotherapy: Tatiana Baker's Story
Tatiana Baker of Boynton Beach, Florida was diagnosed with advanced kidney cancer in the summer of 2014. After running out of treatment options in just a few ...
MedStar Georgetown University Hospital
Immunotherapy Now and Future for Metastatic Renal Cell Carcinoma Jianjun Gao, MD, PhD
Immunotherapy Now and Future for Metastatic Renal Cell Carcinoma Jianjun Gao, MD, PhD.
Kidney Cancer
The status of immunotherapy for metastatic renal cell carcinoma in 2012 David McDermott, MD
The status of immunotherapy for metastatic renal cell carcinoma in 2012 David McDermott, MD Dana Farber Harvard Cancer Center.
Kidney Cancer
Renal cell carcinoma - causes, symptoms, diagnosis, treatment, pathology
What is Renal Cell Carcinoma? It form from epithelial cells in the proximal convoluted tubule of the kidney. Find our complete video library only on Osmosis ...
Osmosis
McDermott: Immunotherapy Agents in Renal Cell Carcinoma
Dr. David McDermott talks about the emerging role of novel immunotherapy agents in renal cell carcinoma at the 2015 American Society of Oncology meeting in ...
Cancer Therapy Advisor
Selecting immunotherapy for RCC
Yann-Alexandre Vano, MD, Georges-Pompidou European Hospital, Paris, France, discusses his thoughts on immunotherapy combinations for renal cell cancer ...
VJOncology
Dr. Uzzo on Trials Investigating Immunotherapy in Kidney Cancer
Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice-president, Physician Services, president, Fox ...
OncLiveTV
Tackling renal cancer with a combination of autologous immunotherapy and sunitinib
Prof Robert Figlin, (Cedars-Sinai, Los Angeles, USA) talks to ecancertv at ASCO GU 2015 about the use of sunitinib in renal cancer when combined with ...
ecancer
Critical Advances in Immunotherapy for Kidney Cancer, with Nizar Tannir
On March 16, 2016, Nizar M. Tannir, M.D., FACP, professor and deputy chair of the department of genitourinary medical oncology at The University of Texas MD ...
Cancer Research Institute
Immunotherapy for Kidney Cancer Patients in the Front-line Setting: Coming Soon?
Current clinical trials are examining the possibility of giving kidney cancer (also called renal cell carcinoma, or RCC) patients immunotherapy as their first option ...
GRACE - Global Resource for Advancing Cancer Education
Ulka N. Vaishampayan, MD, on immunotherapies and renal cell carcinoma treatment algorithms
Dr. Vaishampayan, MD, Department of Oncology, Karmanos Cancer Institute, provides insight into how immunotherapies are being integrated into renal cell ...
OBRoncology
Kidney Cancer and a Second Opinion: Debbie's Immunotherapy Story
After a devastating kidney cancer diagnosis, Debbie sought a second opinion and enrolled in an immunotherapy clinical trial. In January 2015, Debbie was ...
Cancer Research Institute
Eric Jonasch, MD, on integrating immunotherapies into renal cell carcinoma treatment algorithms
Dr. Jonasch, MD, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, ...
OBRoncology
Renal Masses: Inpatient and Outpatient Evaluations (and Updates in Renal Cell Carcinoma)
A lecture for medical professionals about the management of renal masses and updates on renal cell carcinaoma.
Freeman Professional Development
Treatment Options in Renal Cell Carcinoma
The panelists, Robert Figlin, MD; Sandy Srinivas, MD; and Martin Voss, MD, comment on their thought processes when determining which treatment to use in ...
OncLiveTV
